Description

Join us for an important half-day symposium that examines the range of cognitive symptoms and impairment found in patients with depression.

The event features renowned faculty who lead cutting-edge clinical practice teams and research projects in assessment, treatment and management of depression. They examine the latest clinical trial data, discuss the implications of research for enhanced clinical practice, and review regulatory issues that impact researchers, clinicians and others involved in the development of strategies to assess and treat patients with depression.

Faculty represent Massachusetts General Hospital, the MGH Clinical Trial Network and Institute, National Institute of Mental Health, Mount Sinai Medical Center, University of Oxford, and more. The event includes lunch with a roundtable discussion and Q&A session with faculty.

Target Audience

This program is intended for: Mental health researchers and scientists.

This activity is not accredited and may be reportable under the Sunshine Act. Providers may be required to produce their NPI numbers on site.

Pricing

Free of charge.

Agenda

Agenda and faculty subject to change.

WEDNESDAY, OCTOBER 1, 2014

8:00–8:30 am

Cognition in Depression: What Do We Know?
Maurizio Fava, MD
Executive Director, MGH Clinical Trials Network and Institute (CTNI)

9:00–9:30 am

Neurobiology of Cognitive Impairment in Depression
Dan V. Iosifescu, MD, MSSc
Director, Mood and Anxiety Disorders Program, Mount Sinai Medical Center

9:30–10:00 am

Self-Rated Assessment of Cognitive Symptoms in Depression
Grant L. Iverson, PhD
Associate Director, Traumatic Brain Injury Research, Red Sox Foundation and Massachusetts General Hospital Home Base Program

10:00–10:30 am

Objective Measures of Cognitive Impairment in Depression
Guy Goodwin, MD, FMedSci
W.A. Handley Chair of Psychiatry, University of Oxford

10:30–10:45 am

Coffee Break

10:45–11:15 am

Changes in Cognition Following Antidepressant Treatment: Are They All Pseudospecific?
Thomas Laughren, MD
Director of Regulatory Affairs, MGH Clinical Trials Network and Institute (CTNI)

11:15–12:45 pm

Round Table Discussion with Q&A
Moderator: Madhukar H. Trivedi, MD
Faculty: Thomas Laughren, MD; Guy Goodwin, MD, FMedSci; Grant L. Iverson, PhD; Dan V. Iosifescu, MD, MSSc; Maurizio Fava, M
FDA Staff: Mitchell V. Mathis, MD; Robert J. Temple, MD; Ellis F. Unger, MD; Tiffany R. Farchione, MD
NIMH Staff: Sarah E. Morris, PhD

12:45–2:00 pm

Lunch (provided) and Adjournment 

Faculty

  • Medical Officer, Division of Psychiatry Products (DPP), U.S. Food and Drug Administration
  • Director, Clinical Research Program (CRP)
    Executive Vice Chair, Department of Psychiatry
    Executive Director, Clinical Trials Network & Institute (CTNI)
    Massachusetts General Hospital
    Slater Family Professor of Psychiatry,
    Harvard Medical School
  • W.A. Handley Chair of Psychiatry, University of Oxford
  • Director, Mood and Anxiety Disorders Program, Mount Sinai Medical Center
    Associate Professor of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai
  • Director, Neuropsychology Outcome Assessment Laboratory
    Department of Physical Medicine & Rehabilitation
    Harvard Medical School /
    Associate Director, Traumatic Brain Injury Research
    Red Sox Foundation and Massachusetts General Hospital Home Base Program
  • Director, Regulatory Affairs, MGH Clinical Trials Network and Institute
  • Director, Division of Psychiatry Products (DPP), U.S. Food and Drug Administration
  • Chief, Schizophrenia Spectrum Disorders Research Program
    Division of Adult Translational Research
    National Institute of Mental Health
  • Director, Office of Medical Policy, U.S. Food and Drug Administration
  • Professor of Psychiatry, Betty Jo Hay Distinguished Chair in Mental Health, University of Texas Southwestern Medical Center
  • Office of Drug Evaluation I (ODEI), U.S. Food and Drug Administration

CE Information

Release Date: October 1, 2014
Expiration Date: November 1, 2014

CREDIT 

TYPE

 

ACCREDITATION STATEMENT

 

DESIGNATION STATEMENT

0.00

 

This program is not accredited.

 

 

 

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. CME credit is not being offered for this activity.

 

 

  

Even though this event is not accredited, providing information regarding planning, disclosure, and conflict of interest is important to us. Some providers may be able to claim Category 2 CME credit for participating in this activity.


Faculty Disclosure Statement

In accord with the guidelines of the Accreditation Council for Continuing Medical Education (ACCME), planners, speakers and anyone who may have an influence on the content of the activity have been asked to disclose any relationship they or their spouse/partner have to companies producing pharmaceuticals, medical equipment, devices, etc. that may be germane to the content of their presentation. Such disclosure is not intended to suggest or condone bias, but provides participants with information that might be of potential importance to their evaluation of a given presentation.

Resolution of Conflict of Interest (COI)

The MGH Academy has implemented a process to resolve potential COIs for this CME activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.


Hardware/Software Specifications

This internet-based activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


Privacy Policy:

Please click here to review our privacy policy.

Supporters

This program has received support in the form of educational grants from the following companies:

Location

Sheraton Silver Spring Hotel, 8777 Georgia Avenue, Silver Spring, MD, USA